Equities Research Analysts’ price target changes for Tuesday, March 11th:
Alcoa (NYSE:AA) had its target price raised by HC Wainwright to $90.00. The firm currently has a buy rating on the stock.
Advance Auto Parts (NYSE:AAP) had its price target lowered by Evercore ISI from $37.00 to $35.00. The firm currently has an in-line rating on the stock.
Advantage Solutions (NASDAQ:ADV) had its target price cut by Canaccord Genuity Group Inc. from $5.50 to $3.50. They currently have a buy rating on the stock.
Ag Growth International (TSE:AFN) had its price target cut by TD Securities from C$48.00 to C$46.00. They currently have a buy rating on the stock.
Aligos Therapeutics (NASDAQ:ALGS) had its target price trimmed by HC Wainwright from $75.00 to $70.00. The firm currently has a buy rating on the stock.
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by JPMorgan Chase & Co. from $272.00 to $280.00. The firm currently has a neutral rating on the stock.
Asana (NYSE:ASAN) had its price target reduced by UBS Group AG from $18.00 to $14.00. UBS Group AG currently has a neutral rating on the stock.
Asana (NYSE:ASAN) had its price target lowered by Scotiabank from $18.00 to $12.00. Scotiabank currently has a sector perform rating on the stock.
Asana (NYSE:ASAN) had its price target reduced by Piper Sandler from $27.00 to $18.00. They currently have an overweight rating on the stock.
Asana (NYSE:ASAN) had its target price trimmed by Robert W. Baird from $23.00 to $13.00. Robert W. Baird currently has a neutral rating on the stock.
Asana (NYSE:ASAN) had its price target trimmed by Bank of America Co. from $30.00 to $25.00. They currently have a buy rating on the stock.
Asana (NYSE:ASAN) had its target price reduced by Jefferies Financial Group Inc. from $19.00 to $15.00. The firm currently has a hold rating on the stock.
Asana (NYSE:ASAN) had its price target lowered by DA Davidson from $20.00 to $12.00. They currently have a neutral rating on the stock.
Asana (NYSE:ASAN) had its target price lowered by JPMorgan Chase & Co. from $15.00 to $13.00. The firm currently has an underweight rating on the stock.
AvePoint (NASDAQ:AVPT) had its target price trimmed by Citigroup Inc. from $18.00 to $16.00. They currently have a neutral rating on the stock.
BlackBerry (NYSE:BB) had its target price raised by Canaccord Genuity Group Inc. from $3.00 to $4.75. The firm currently has a hold rating on the stock.
BioNTech (NASDAQ:BNTX) had its target price raised by BMO Capital Markets from $130.00 to $143.00. The firm currently has an outperform rating on the stock.
BioNTech (NASDAQ:BNTX) had its target price lowered by Morgan Stanley from $145.00 to $139.00. They currently have an overweight rating on the stock.
Casey’s General Stores (NASDAQ:CASY) had its target price cut by Evercore ISI from $460.00 to $450.00. The firm currently has an outperform rating on the stock.
CenterPoint Energy (NYSE:CNP) had its price target boosted by JPMorgan Chase & Co. from $34.00 to $36.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Coinbase Global (NASDAQ:COIN) had its price target reduced by Mizuho from $280.00 to $217.00. Mizuho currently has a neutral rating on the stock.
Costco Wholesale (NASDAQ:COST) had its price target increased by Evercore ISI from $1,050.00 to $1,070.00. The firm currently has an outperform rating on the stock.
Campbell Soup (NASDAQ:CPB) had its target price reduced by DA Davidson from $46.00 to $39.00. The firm currently has a neutral rating on the stock.
CRH (NYSE:CRH) had its target price trimmed by JPMorgan Chase & Co. from $118.00 to $114.00. The firm currently has an overweight rating on the stock.
CervoMed (NASDAQ:CRVO) had its price target boosted by Roth Mkm from $7.00 to $15.00. Roth Mkm currently has a buy rating on the stock.
Carvana (NYSE:CVNA) had its target price trimmed by Evercore ISI from $250.00 to $240.00. The firm currently has an in-line rating on the stock.
Dominion Energy (NYSE:D) had its target price increased by JPMorgan Chase & Co. from $58.00 to $59.00. They currently have a neutral rating on the stock.
Delta Air Lines (NYSE:DAL) had its target price trimmed by Barclays PLC from $90.00 to $80.00. They currently have an overweight rating on the stock.
Delta Air Lines (NYSE:DAL) had its target price cut by UBS Group AG from $90.00 to $77.00. They currently have a buy rating on the stock.
DarioHealth (NASDAQ:DRIO) had its target price cut by Stifel Nicolaus from $3.50 to $2.00. They currently have a buy rating on the stock.
Duke Energy (NYSE:DUK) had its price target raised by JPMorgan Chase & Co. from $114.00 to $121.00. They currently have a neutral rating on the stock.
Duke Energy (NYSE:DUK) had its price target increased by BMO Capital Markets from $123.00 to $128.00. BMO Capital Markets currently has an outperform rating on the stock.
enGene (NASDAQ:ENGN) had its target price trimmed by Morgan Stanley from $37.00 to $34.00. They currently have an overweight rating on the stock.
Enterprise Products Partners (NYSE:EPD) had its price target boosted by Morgan Stanley from $36.00 to $38.00. The firm currently has an equal weight rating on the stock.
Equitable (NYSE:EQH) had its price target raised by Morgan Stanley from $66.00 to $68.00. They currently have an overweight rating on the stock.
Entergy (NYSE:ETR) had its target price raised by JPMorgan Chase & Co. from $87.00 to $98.00. The firm currently has an overweight rating on the stock.
Franco-Nevada (NYSE:FNV) (TSE:FNV) had its price target raised by UBS Group AG from $165.00 to $170.00. They currently have a buy rating on the stock.
Franco-Nevada (NYSE:FNV) (TSE:FNV) had its price target increased by Scotiabank from $145.00 to $150.00. The firm currently has a sector perform rating on the stock.
Franco-Nevada (NYSE:FNV) (TSE:FNV) had its price target increased by HC Wainwright from $155.00 to $165.00. The firm currently has a buy rating on the stock.
Guess? (NYSE:GES) had its price target cut by UBS Group AG from $15.00 to $12.00. The firm currently has a neutral rating on the stock.
Gilead Sciences (NASDAQ:GILD) had its target price increased by Morgan Stanley from $123.00 to $130.00. The firm currently has an overweight rating on the stock.
General Mills (NYSE:GIS) had its target price reduced by JPMorgan Chase & Co. from $62.00 to $60.00. They currently have a neutral rating on the stock.
Genmab A/S (NASDAQ:GMAB) had its target price reduced by Truist Financial Co. from $50.00 to $45.00. They currently have a buy rating on the stock.
Hamilton Insurance Group (NYSE:HG) had its target price increased by Keefe, Bruyette & Woods from $23.00 to $25.00. The firm currently has an outperform rating on the stock.
HIVE Digital Technologies (NASDAQ:HIVE) had its price target trimmed by Cantor Fitzgerald from $10.00 to $8.00. They currently have an overweight rating on the stock.
Illumina (NASDAQ:ILMN) had its target price trimmed by Canaccord Genuity Group Inc. from $135.00 to $115.00. Canaccord Genuity Group Inc. currently has a hold rating on the stock.
Inozyme Pharma (NASDAQ:INZY) had its price target lowered by Piper Sandler from $30.00 to $23.00. The firm currently has an overweight rating on the stock.
Inozyme Pharma (NASDAQ:INZY) had its target price reduced by Needham & Company LLC from $23.00 to $15.00. Needham & Company LLC currently has a buy rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price cut by JPMorgan Chase & Co. from $51.00 to $47.00. They currently have a neutral rating on the stock.
James River Group (NASDAQ:JRVR) had its target price reduced by Truist Financial Co. from $6.00 to $5.00. They currently have a hold rating on the stock.
Kodiak Gas Services (NYSE:KGS) had its target price boosted by Truist Financial Co. from $45.00 to $47.00. Truist Financial Co. currently has a buy rating on the stock.
CarMax (NYSE:KMX) had its target price reduced by Evercore ISI from $107.00 to $105.00. Evercore ISI currently has an outperform rating on the stock.
Kroger (NYSE:KR) had its price target increased by Evercore ISI from $73.00 to $74.00. They currently have an outperform rating on the stock.
Kohl’s (NYSE:KSS) had its price target lowered by JPMorgan Chase & Co. from $11.00 to $9.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Stride (NYSE:LRN) had its target price increased by Canaccord Genuity Group Inc. from $135.00 to $145.00. They currently have a buy rating on the stock.
Intuitive Machines (NASDAQ:LUNR) had its target price cut by Roth Mkm from $20.00 to $12.00. They currently have a buy rating on the stock.
Mplx (NYSE:MPLX) had its price target boosted by Morgan Stanley from $56.00 to $62.00. The firm currently has an equal weight rating on the stock.
Vail Resorts (NYSE:MTN) had its target price boosted by JPMorgan Chase & Co. from $166.00 to $167.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Vail Resorts (NYSE:MTN) had its price target cut by Morgan Stanley from $197.00 to $178.00. The firm currently has an equal weight rating on the stock.
Myomo (NYSEAMERICAN:MYO) had its target price boosted by Craig Hallum from $9.00 to $11.00. The firm currently has a buy rating on the stock.
NextEra Energy (NYSE:NEE) had its target price increased by JPMorgan Chase & Co. from $90.00 to $91.00. They currently have an overweight rating on the stock.
ServiceNow (NYSE:NOW) had its target price reduced by UBS Group AG from $1,250.00 to $1,000.00. They currently have a buy rating on the stock.
ServiceNow (NYSE:NOW) had its price target reduced by Mizuho from $1,210.00 to $1,100.00. The firm currently has an outperform rating on the stock.
Nucor (NYSE:NUE) had its price target raised by JPMorgan Chase & Co. from $150.00 to $156.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
OnKure Therapeutics (NASDAQ:OKUR) had its target price trimmed by Oppenheimer Holdings Inc. from $35.00 to $30.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Oracle (NYSE:ORCL) had its price target trimmed by BMO Capital Markets from $205.00 to $175.00. The firm currently has a market perform rating on the stock.
Oracle (NYSE:ORCL) had its price target lowered by Piper Sandler from $210.00 to $190.00. They currently have an overweight rating on the stock.
Oracle (NYSE:ORCL) had its target price lowered by Barclays PLC from $212.00 to $202.00. The firm currently has an overweight rating on the stock.
Oracle (NYSE:ORCL) had its target price lowered by Stifel Nicolaus from $175.00 to $150.00. They currently have a hold rating on the stock.
Oracle (NYSE:ORCL) had its target price reduced by Morgan Stanley from $175.00 to $170.00. The firm currently has an equal weight rating on the stock.
Oracle (NYSE:ORCL) had its target price reduced by Evercore ISI from $200.00 to $185.00. Evercore ISI currently has an outperform rating on the stock.
Oracle (NYSE:ORCL) had its price target reduced by Bank of America Co. from $195.00 to $175.00. The firm currently has a neutral rating on the stock.
Oracle (NYSE:ORCL) had its target price trimmed by Cantor Fitzgerald from $214.00 to $175.00. They currently have an overweight rating on the stock.
Oracle (NYSE:ORCL) had its target price cut by UBS Group AG from $210.00 to $200.00. UBS Group AG currently has a buy rating on the stock.
Oracle (NYSE:ORCL) had its target price reduced by JPMorgan Chase & Co. from $140.00 to $135.00. They currently have a neutral rating on the stock.
Paymentus (NYSE:PAY) had its target price lowered by JPMorgan Chase & Co. from $31.00 to $29.00. The firm currently has a neutral rating on the stock.
Paymentus (NYSE:PAY) had its target price trimmed by Robert W. Baird from $40.00 to $36.00. Robert W. Baird currently has an outperform rating on the stock.
PBF Energy (NYSE:PBF) had its target price reduced by TD Cowen from $19.00 to $17.00. They currently have a sell rating on the stock.
PBF Energy (NYSE:PBF) had its price target cut by JPMorgan Chase & Co. from $31.00 to $29.00. The firm currently has a neutral rating on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its target price increased by Truist Financial Co. from $60.00 to $76.00. The firm currently has a buy rating on the stock.
Protagonist Therapeutics (NASDAQ:PTGX) had its target price boosted by BMO Capital Markets from $62.00 to $72.00. BMO Capital Markets currently has an outperform rating on the stock.
SentinelOne (NYSE:S) had its price target reduced by Robert W. Baird from $30.00 to $28.00. They currently have an outperform rating on the stock.
SentinelOne (NYSE:S) had its target price reduced by Barclays PLC from $24.00 to $22.00. The firm currently has an equal weight rating on the stock.
SentinelOne (NYSE:S) had its price target lowered by Westpark Capital from $34.00 to $31.00. They currently have a buy rating on the stock.
StandardAero (NYSE:SARO) had its price target boosted by UBS Group AG from $27.00 to $28.00. UBS Group AG currently has a neutral rating on the stock.
Sprouts Farmers Market (NASDAQ:SFM) had its target price boosted by JPMorgan Chase & Co. from $131.00 to $136.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Sprouts Farmers Market (NASDAQ:SFM) had its price target cut by Evercore ISI from $185.00 to $180.00. The firm currently has an outperform rating on the stock.
Surgery Partners (NASDAQ:SGRY) had its price target cut by Macquarie from $34.00 to $33.00. The firm currently has an outperform rating on the stock.
Sphere Entertainment (NYSE:SPHR) had its price target trimmed by Macquarie from $45.00 to $40.00. Macquarie currently has a neutral rating on the stock.
Simpson Manufacturing (NYSE:SSD) had its price target cut by DA Davidson from $195.00 to $185.00. The firm currently has a neutral rating on the stock.
ONE Group Hospitality (NASDAQ:STKS) had its price target lowered by Stephens from $6.00 to $5.00. The firm currently has an overweight rating on the stock.
Steel Dynamics (NASDAQ:STLD) had its target price increased by JPMorgan Chase & Co. from $132.00 to $140.00. The firm currently has a neutral rating on the stock.
Smurfit Westrock (NYSE:SW) had its price target reduced by Morgan Stanley from $66.00 to $64.00. Morgan Stanley currently has an overweight rating on the stock.
TruBridge (NASDAQ:TBRG) had its price target increased by Stephens from $23.00 to $28.00. The firm currently has an equal weight rating on the stock.
TruBridge (NASDAQ:TBRG) had its price target increased by Cantor Fitzgerald from $20.00 to $29.00. The firm currently has an overweight rating on the stock.
Telos (NASDAQ:TLS) had its price target reduced by BMO Capital Markets from $4.50 to $3.00. BMO Capital Markets currently has a market perform rating on the stock.
Telos (NASDAQ:TLS) had its price target lowered by DA Davidson from $3.50 to $2.50. The firm currently has a neutral rating on the stock.
Tenaya Therapeutics (NASDAQ:TNYA) had its target price cut by HC Wainwright from $18.00 to $5.00. HC Wainwright currently has a buy rating on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its price target increased by Oppenheimer Holdings Inc. from $12.00 to $20.00. The firm currently has an outperform rating on the stock.
Toro (NYSE:TTC) had its price target lowered by DA Davidson from $86.00 to $80.00. DA Davidson currently has a neutral rating on the stock.
UroGen Pharma (NASDAQ:URGN) had its price target cut by HC Wainwright from $64.00 to $55.00. HC Wainwright currently has a buy rating on the stock.
USA Compression Partners (NYSE:USAC) had its price target raised by JPMorgan Chase & Co. from $23.00 to $24.00. JPMorgan Chase & Co. currently has an underweight rating on the stock.
Venture Global (NYSE:VG) had its target price lowered by Mizuho from $25.00 to $18.00. They currently have an outperform rating on the stock.
Venture Global (NYSE:VG) had its price target reduced by Wells Fargo & Company from $18.00 to $11.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Ventas (NYSE:VTR) had its price target increased by Morgan Stanley from $65.00 to $70.00. They currently have an equal weight rating on the stock.
Walmart (NYSE:WMT) had its price target reduced by Evercore ISI from $107.00 to $100.00. They currently have an outperform rating on the stock.
WNS (NYSE:WNS) had its target price boosted by Needham & Company LLC from $65.00 to $70.00. They currently have a buy rating on the stock.
United States Steel (NYSE:X) had its target price boosted by JPMorgan Chase & Co. from $40.00 to $43.00. They currently have an overweight rating on the stock.
Receive News & Ratings for Alcoa Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcoa Co and related companies with MarketBeat.com's FREE daily email newsletter.
